Author(s) :

Nitya Sarvesha.

Volume/Issue :

Abstract :

Breast cancer currently has effective detection and treatment processes, but there are still many aspects that the process lacks which causes breast cancer to be in need of more accurate tools. Currently, liquid biopsies have shown great promise in the future of detection and management of cancer. Liquid biopsies are able to be noninvasive, performed more frequently than a single biopsy, and able to gain a comprehensive understanding of the entire tumor through a single blood test. However, liquid biopsies need to be more sensitive and accurate in its detection to be implemented in the future. We conducted a search for relevant papers that gave current and future understandings on the implementations of liquid biopsy in women with early and late, metastatic stages of breast cancer. Through these studies and papers, most studies suggest that higher sensitivities will only be improved with multi-modeled assays by using multiple biomarkers to help to increase sensitivity and improve reliability of diagnosis. This gives hope for liquid biopsies to be continued to be developed for progression on cancer detection for women with high risk in breast cancer with the use of multiple biomarkers.